Yeshiva University

Yeshiva University, a private, tax-exempt educational institution headquartered in New York, New York, operates as a grant recipient to the federal government, conducting academic research and providing educational programs rather than selling goods or services as a prime contractor. The institution competes for federal research funding across multiple agencies without set-aside designations and also receives tuition reimbursement from the Department of the Navy Bureau of Medicine and Surgery.

Yeshiva University's federal footprint centers on research grants from the National Science Foundation and the National Institutes of Health, with the institution acting as prime recipient on the majority of its awards (82% prime, 18% as sub-recipient). The top funding sources by potential value are the NIH National Heart, Lung, and Blood Institute ($114 million across 10 awards) and the Navy Bureau of Medicine and Surgery ($1 million across 29 awards, primarily tuition reimbursement). The institution also receives funding from the NSF Division of Mathematical Sciences, Division of Molecular and Cellular Biosciences, Computer and Information Science and Engineering program, and the National Institute of Child Health and Human Development. Representative prime research grants include a $579,398 NSF Biological Sciences award for discovery and engineering of calcium-regulated photoproteins from marine siphonophores (award date August 1, 2025, completion July 31, 2028), a $399,999 NSF STEM Education award for developing cybersecurity education curriculum and platforms in mobile health (August 15, 2024 through July 31, 2027), and a $203,014 NSF Computer and Information Science and Engineering collaborative research award on cybersecurity and privacy in Artificial Internet of Things systems with York College (October 1, 2025 through January 31, 2028). Additional representative work includes a $300,000 NSF Mathematical and Physical Sciences grant on energy growth, dissipation, and control in Hamiltonian systems (July 15, 2023 through June 30, 2026) and a $594,125 NSF Biological Sciences award on RNA transport and localization tools in Drosophila (August 15, 2024 through July 31, 2027).

The institution serves 41 distinct federal agencies, with award volume concentrated among a small number of customers. The top five funding agencies by award count account for 49% of recent awards, with the Navy Bureau of Medicine and Surgery dominating volume (29 awards), while the NIH National Heart, Lung, and Blood Institute anchors the dollar value share. NSF appears prominently in both rankings with 26 awards, and the broader HHS research complex (NIH, HRSA, and specialty institutes) collectively represents substantial activity. Award activity has grown year over year, from 7 awards in 2022 to 20 in 2024, though 2025–2026 show moderation at 11 and 8 awards respectively. Eight awards are scheduled for completion within the next twenty-four months, representing potential recompete opportunity.

The institution operates through sub-recipient relationships on NIH-funded research, working with prime recipients including Albert Einstein College of Medicine (multiple aging, diabetes, and asthma-related studies), Research Foundation of the City University of New York, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and Icahn School of Medicine at Mount Sinai. Sub-award work spans clinical research coordination, graduate student training, data analysis, and supervision of behavioral interventions in areas including diabetes prevention, HIV-related mobility, asthma management, and migraine treatment. Service Contract Inventory reporting shows minimal SCI-captured activity — four sub records totaling fewer than one FTE across fiscal years 2022 and 2024 — a reflection that Yeshiva's federal work is predominantly research-grant-based rather than service-contract-based. The institution's federal grant portfolio emphasizes basic and applied research in mathematics, biology, computer science, and engineering, with secondary emphasis on cybersecurity and health education curriculum development. Yeshiva University also operates Albert Einstein College of Medicine as a named subsidiary, which serves as a major teaming partner on NIH-funded research initiatives.